• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 16 of 36
Pfizer FDA approval COVID vaccine mandates
HealthFull FDA approval of Pfizer’s COVID vaccine is coming soon. What that means
By Sy MukherjeeAugust 5, 2021
Competitor to Elon Musk’s Neuralink beats it to FDA trial of brain-to-computer implant
TechCompetitor to Elon Musk’s Neuralink beats it to FDA trial of brain-to-computer implant
By Sarah McBride and BloombergJuly 28, 2021
Biden-Ohio-Town Hall-Covid Vaccine Full Approval
What full FDA approval this fall means for COVID vaccines going forward
By Marco Quiroz-GutierrezJuly 22, 2021
Shares of NeuroMetrix more than double after positive FDA news
FinanceShares of NeuroMetrix more than double after positive FDA news
By Chris MorrisJuly 20, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
NewslettersThe never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
Amazon offers its in-home COVID-19 tests to consumers
HealthAmazon offers its in-home COVID-19 tests to consumers
By Chris MorrisJuly 6, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
HealthPressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
A medical assistant transports the Moderna Covid-19 vaccine ready to be administered at a vaccination site at Kedren Community Health Center, in South Central Los Angeles, California on February 16, 2021.
HealthAfter 600 emergency use authorizations for COVID, experts worry the FDA has gone too far
By Kat EschnerJune 7, 2021
FDA Biogen Alzheimer's Janet Woodcock
HealthPresident Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021
FDA announces plan to ban menthol cigarettes
HealthFDA announces plan to ban menthol cigarettes
By Matthew Perrone and The Associated PressApril 29, 2021
Despite incredibly low blood clot risks, the J&J vaccine pause was warranted, experts say
HealthDespite incredibly low blood clot risks, the J&J vaccine pause was warranted, experts say
By Marco Quiroz-GutierrezApril 13, 2021
Everything we know about the Johnson & Johnson COVID vaccine pause (so far)
HealthEverything we know about the Johnson & Johnson COVID vaccine pause (so far)
By Chris MorrisApril 13, 2021
Rapid COVID tests are coming to market alongside vaccines to help America return to normal
HealthRapid COVID tests are coming to market alongside vaccines to help America return to normal
By Hannah Norman and Kaiser Health NewsApril 1, 2021
Photo of gloved hand holding syringe and vial of Astrazeneca vaccine
HealthAstraZeneca’s U.S. trial results debacle further widens its credibility gap
By Jeremy KahnMarch 23, 2021
Why AstraZeneca and J&J’s vaccines are still on hold in the U.S.
HealthWhy AstraZeneca and J&J’s vaccines are still on hold in the U.S.
By Sarah Jane Tribble and Kaiser Health NewsFebruary 26, 2021
1...
  • 14
  • 15
  • 16
  • 17
  • 18
...36
Most Popular
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.